Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B |
| Gross profit | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | $8.29B | $8.28B | $8.36B | $8.36B | $8.14B | $8.00B | $7.92B | $7.86B |
| Operating expenses | $17.16B | $16.25B | $16.30B | $16.20B | $15.64B | $15.47B | $15.43B | $15.08B |
| Operating income | $3.07B | $2.86B | $3.22B | $2.97B | $2.97B | $2.86B | $2.86B | $2.41B |
| Operating margin | 15.2% | 15.0% | 16.5% | 15.5% | 15.9% | 15.6% | 15.6% | 13.8% |
| EBITDA | $4.01B | $3.79B | $4.13B | $3.85B | $3.83B | $3.72B | $3.72B | $3.25B |
| Interest expense | −$599.00M | −$584.00M | −$572.00M | −$561.00M | −$568.00M | −$547.00M | −$528.00M | −$515.00M |
| Income before taxes | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B |
| Income taxes | $564.00M | $430.00M | $509.00M | $515.00M | $524.00M | $502.00M | $447.00M | $424.00M |
| Net income | $1.93B | $1.86B | $2.16B | $1.90B | $1.89B | $1.83B | $1.69B | $1.48B |
| Net margin | 9.5% | 9.7% | 11.1% | 9.9% | 10.2% | 10.0% | 9.2% | 8.5% |
| EPS, basic | $7.70 | $7.25 | $8.29 | $7.05 | $6.91 | $6.52 | $5.71 | $4.94 |
| EPS, diluted | $7.62 | $7.15 | $8.15 | $6.96 | $6.83 | $6.45 | $5.63 | $4.88 |
| Diluted shares | 222.83M | 226.65M | 230.45M | 236.18M | 241.91M | 249.44M | 255.22M | 259.92M |
Figures describe HCA Healthcare shares, not any token. As of Jul 28, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.